欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2015, Vol. 20 ›› Issue (1): 91-95.

• 综述与讲座 • 上一篇    下一篇

抗结核药所致肝损害与药物代谢酶等基因多态性的关联性研究

刘瑜1,2, 高瑞1, 陈昱1, 陈琳1, 夏春华1, 邓国防2   

  1. 1南昌大学临床药理研究所/江西省临床药物代谢动力学重点实验室, 南昌 330006,江西;
    2江西省胸科医院, 南昌 330006,江西;
    3深圳市第三人民医院肺二科, 深圳 518112,广东
  • 收稿日期:2014-04-09 修回日期:2014-08-24 发布日期:2020-07-20
  • 通讯作者: 夏春华,通信作者,男,教授,硕士生导师,主要从事药物代谢动力学及临床药理学研究。Tel:0791-86360654 E-mail:xch720917@163.com邓国防,通信作者,男,主任医师,硕士生导师,主要从事抗结核药物肝损伤机制研究。Tel:13530027001 E-mail:jxxk1035@yeah.net
  • 作者简介:刘瑜,女,硕士研究生,研究方向:临床药学及药代动力学。Tel:13807083660 E-mail:362550422@qq.com
  • 基金资助:
    国家自然科学基金(81060275,81160411);江西省青年科学家培养对象(20133BCB23006);江西省自然科学基金(20132BAB205013);江西省科技支撑计划(20132BBG70100)

Study progress on anti-tuberculosis drug-induced liver damage associated with drug-metabolizing enzyme gene polymorphism

LIU Yu1,2, GAO Rui1, CHEN Yu1, CHEN Lin1, XIA Chun-hua1, DENG Guo-fang2   

  1. 1Clinical Pharmacology Institution, Nanchang University/Jiangxi Key Laboratory of Clinical Pharmacokinetics, Nanchang 330006, Jiangxi, China;
    2Jiangxi Chest Hospital, Nanchang 330006, Jiangxi, China;
    3 Third People's Hospital of Shenzhen, Shenzhen 518112, Guangdong, China
  • Received:2014-04-09 Revised:2014-08-24 Published:2020-07-20

摘要: 肺结核是由结核分枝杆菌(MTB)感染引起的慢性传染病,是严重危害人类健康的传染病之一。抗结核药物所致肝损害(anti-tuberculosis drug-induced hepatotoxicity, ATDH)是结核病治疗过程中备受关注的问题。有关ATDH的致病机制尚不完全明确,深入探讨肝损害发生的机制显得尤为重要。抗结核药在体内经各种代谢酶及转运体作用形成毒性较低的产物,而这些酶的基因多态性很可能是影响ATDH的重要因素。本文就相关酶的基因多态性与ATDH致病原因作一概述。

关键词: 抗结核药物所致肝损害, 抗结核药, 药物代谢酶, 转运体, 基因多态性

Abstract: Tuberculosis is a chronic infectious disease caused by mycobacterium and is one of the serious infectious diseases harmful to human health. Anti-tuberculosis drug-induced hepatotoxicity (ATDH) draws more attention in the treatment of tuberculosis recently. It is worthy of summarizing the detailed mechanism about ATDH which is still not clear today. It is known to us that anti-tuberculosis drugs are formed less toxic metabolite in vivo by various metabolic enzymes and transporters, and the polymorphisms of transporters and enzymes are likely to be the important factors associated with ATDH. This paper provides an overview about the correlation between drug metabolic enzymes polymorphisms and ATDH.

Key words: ATDH, anti-tuberculosis drug, drug metabolic enzymes, drug transporters, polymorphism

中图分类号: